Methsuximide
- Generic Name
- Methsuximide
- Brand Names
- Celontin
- Drug Type
- Small Molecule
- Chemical Formula
- C12H13NO2
- CAS Number
- 77-41-8
- Unique Ingredient Identifier
- 0G76K8X6C0
- Background
Mesuximide (or methsuximide) is an anticonvulsant medication. It is sold by Pfizer under the name Petinutin.
- Indication
For the control of absence (petit mal) seizures that are refractory to other drugs.
- Associated Conditions
- Refractory absence Seizures
- Associated Therapies
- -
Population Pharmacokinetics of Antiepileptic in Pediatrics
Recruiting
- Conditions
- Interventions
- Biological: Valproic acidBiological: carbamazepineBiological: phenobarbitalBiological: phenytoinBiological: levetiracetamBiological: lamotrigineBiological: topiramateBiological: oxcarbazepineBiological: stiripentolBiological: clobazamBiological: brivaracétamBiological: felbamateBiological: lacosamideBiological: rufinamideBiological: gabapentineBiological: pregabalineBiological: sultiameBiological: tiagabineBiological: vigabatrineBiological: mesuximideBiological: primidoneBiological: perampanelBiological: ethosuximideBiological: zonisamideBiological: cannabidiolOther: genetic polymorphisms
- First Posted Date
- 2017-06-22
- Last Posted Date
- 2024-10-30
- Lead Sponsor
- Assistance Publique - HĂ´pitaux de Paris
- Target Recruit Count
- 1000
- Registration Number
- NCT03196466
- Locations
- 🇫🇷
AP-HP Cochin, Paris, France
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath